Depixus
PrivateLast Round
Series A
Dec 15, 2021
Est. Valuation
$6.71M
Total Funding Raised
$39.82M
Company Overview
Depixus is a biotechnology company that provides innovative technology for real-time analysis of individual biomolecular interactions at scale, allowing researchers to swiftly analyze full genomic regions and uncover new biological pathways and disease mechanisms for precision medicine development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Depixus Comparables
Compare Depixus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LUMICKS | 81% | |
| Nicoya Lifesciences Inc. | 81% | |
| Fida Biosystems | 80% | |
Depixus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 15, 2021 | ||||
| Grant | Nov 1, 2018 | ||||
| Grant | Sep 1, 2016 | ||||
| Seed | May 6, 2016 | ||||
| Grant | Jun 1, 2015 |
Depixus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| European Commission (Horizon Europe) | Grant |
| Arix Bioscience | Seed, Series A |
| Lansdowne Partners | Series A |
| Casdin Capital | Series A |
| Bpifrance | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 15, 2021
$35M round led by Lansdowne Partners and Bpifrance.
- May 6, 2016
$1.41M round led by Arix Bioscience.
Depixus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Depixus's valuation, stock price, and market status.